Disrupting this communication through CDA or P2Y6 inhibition leads to the infiltration of effector T cells into the tumor, transforming it into a T cell-inflamed or ‘hot’ state, a condition that enables the effectiveness of anti-PD-1 treatment. The gene discussed is P2RY6; the disease is neoplasm.